NASDAQ: ADMS       Adamas Pharma
Last Price Today's Change   Day's Range   Trading Volume
5.54   -0.28 (4.81%)  5.16 - 5.94  900,000


Avg Volume (4 weeks):310,168
4 Weeks Range:4.11 - 5.94
4 Weeks Price Volatility (%):
52 Weeks Range:1.90 - 6.02
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Adamas Pharmaceuticals Inc was incorporated in the State of Delaware on November 15, 2000. It is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102 (amantadine hydrochloride) for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia. The Company's portfolio also includes two drugs commercially available in the United States for indications relating to Alzheimer's disease: Namzaric capsules and Namenda XR extended release capsules.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2563  6639  404  79 

Top 10 Active Counters
 NAKD 1.38+0.988 
 AMC 19.90-0.44 
 NOK 6.55+1.56 
 SNDL 0.60+0.10 
 CTRM 0.532+0.182 
 BB 25.10+4.85 
 EXPR 9.55+1.62 
 GNUS 3.06+1.43 
 UVXY 13.87+2.47 
 AAL 16.56+1.14